Rabourn Zaremba Biography and Net Worth

Insider of Opus Genetics

Ms. Amy Zaremba Rabourn, C.P.A., MAcc, holds the position of Senior Vice President of Finance at Opus Genetics, Inc. In this significant role, Ms. Rabourn contributes to the company's financial leadership and strategy, working closely with the CFO. Her responsibilities likely encompass financial planning and analysis, budgeting, forecasting, and ensuring the accuracy and compliance of financial operations. With her credentials as a Certified Public Accountant (CPA) and a Master of Accountancy (MAcc), Ms. Rabourn brings a wealth of technical expertise and a commitment to financial integrity. Her contributions are vital in supporting Opus Genetics' financial health and facilitating its continued growth and investment in groundbreaking gene therapies.

What is Rabourn Amy Zaremba's net worth?: The estimated net worth of Rabourn Amy Zaremba is at least $964.11 thousand as of April 23rd, 2026. Mr. Zaremba owns 188,671 shares of Opus Genetics stock worth more than $964,109 as of April 30th. This net worth evaluation does not reflect any other assets that Mr. Zaremba may own. Learn More about Rabourn Amy Zaremba's net worth.
How do I contact Rabourn Amy Zaremba?: The corporate mailing address for Mr. Zaremba and other Opus Genetics executives is 37000 GRAND RIVER AVE. SUITE 120, FARMINGTON HILLS MI, 48335. Opus Genetics can also be reached via phone at 248-957-9024 and via email at [email protected]. Learn More on Rabourn Amy Zaremba's contact information.
Has Rabourn Amy Zaremba been buying or selling shares of Opus Genetics?: In the last ninety days, Rabourn Amy Zaremba has sold $8,533.20 in shares of Opus Genetics stock. Most recently, Rabourn Amy Zaremba sold 1,641 shares of the business's stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $5.20, for a transaction totalling $8,533.20. Following the completion of the sale, the insider now directly owns 188,671 shares of the company's stock, valued at $981,089.20. Learn More on Rabourn Amy Zaremba's trading history.
Who are Opus Genetics' active insiders?: Opus Genetics' insider roster includes Robert Gagnon (CFO), Cam Gallagher (Director), Cam Gallagher (Director), Ashwath Jayagopal (Insider), George Magrath (CEO), Joseph Schachle (COO), Benjamin Yerxa (President), Benjamin Yerxa (President), and Rabourn Zaremba (Insider). Learn More on Opus Genetics' active insiders.
Are insiders buying or selling shares of Opus Genetics?: During the last year, Opus Genetics insiders bought shares 2 times. They purchased a total of 164,000 shares worth more than $323,890.00. During the last year, insiders at the sold shares 11 times. They sold a total of 4,073,395 shares worth more than $8,982,278.31. The most recent insider tranaction occured on April, 23rd when President Benjamin R Yerxa sold 7,470 shares worth more than $39,142.80. Insiders at Opus Genetics own 11.7% of the company. Learn More about insider trades at Opus Genetics.
Information on this page was last updated on 4/23/2026.

Rabourn Amy Zaremba Insider Trading History at Opus Genetics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
4/23/2026	Sell	1,641	$5.20	$8,533.20	188,671
3/16/2026	Sell	2,816	$5.25	$14,784.00	190,312

Rabourn Amy Zaremba Buying and Selling Activity at Opus Genetics

Opus Genetics Company Overview

Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.

Today's Range

Now: $5.11

$4.70

$5.23

50 Day Range

MA: $4.77

$3.39

$5.75

2 Week Range

Now: $5.11

$0.90

$5.81

Volume

1,436,817 shs

Average Volume

905,997 shs

Market Capitalization

$364.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.52